Study on clean production of pharmaceutical enterprises: a case study on Yangzhou Pharmaceutical Factory;

Construction and application of ontology for pharmaceutical enterprise based on OWL;

Research on the Innovation Pathes of Chinese and Foreign Pharmaceutical Enterprises Based on Integration;

Management characteristics of scientific research institutions in pharmaceutical enterprises and new ideas.;

Study on CRM & Its Application in Pharmaceutical Enterprises of Hangzhou;

Taking pharmaceutical enterprises in Hunan Liuyang Biomedical Park as samples to analyze, this paper set up an evaluation index system on Technical Innovation Ability.

Because of the special traits of medicine, there are some special demands for material requirement management of pharmacy enterprises.

This paper analyzes on the present situation of Chinese pharmacy enterprise, probes into the problems existing in the supply chain of the pharmacy enterprise, and forecasts the developing prospect of the pharmacy enterprise.

According to the design flow of production planning system,this paper puts forward the function model of production planning system for pharmacy enterprise on the basis of analyzing the production characteristic of pharmacy enterprise,and makes a particular analysis on the system function.

GMP-Based Identification Requirement of Medicine Enterprise of ERP Construction;

By using multi-class comprehensive judgment,the influence factors for marketing ability in medicine enterprise is discussed the index weight,model are discussed,a quantitative analysis model is constructed and some suggestions are given in the end after quantitative analyzing.

Research on Inventory Management Theory and Methodology Innovation and Demonstration in Pharmaceutical Industry;

China s entry into WTO, Chinese market has become a part of the world market, and the competition between the pharmaceutical industry has been increasingly fierce.

So supporting the Chinese Pharmaceutical industry is a major act of revitalizing the national economy,and it should be develop and create a multi-channel means of financing pharmaceutical enterprises by increasing capital investment in the pharmaceutical industry.